Barclays analyst Raimo Lenschow maintains Snowflake (NYSE:SNOW) with a Overweight and lowers the price target from $180 to $169.
2seventy bio Appoints Steven Bernstein, M.D. As Chief Medical Officer
Steven Bernstein, M.D. appointed to chief medical officer
Susan Abu-Absi, Ph.D. promoted to chief technology & manufacturing officer
2seventy bio, Inc. (NASDAQ:TSVT) announced that Steven Bernstein, M.D. will join